The radiosensitizing effects of a STAT3/HDAC dual-target inhibitor derived from isoalantolactone in solid tumor models

Abstract Multi-target combination therapy has emerged as a promising anti-cancer strategy. STAT3 and HDAC are key contributors to tumorigenesis and progression. We previously reported the design of a novel dual-target inhibitor of STAT3 and HDAC (named mhl-28), which was developed by employing a nat...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Qi Wang, Haiyan Qiu, Rongfei Zhu, Rong Li, Jiahan Qiao, Chun Fu, Yaxin Tang, Aihua Shen, Junfang Yan, Denggao Zhao, Burong Hu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2026-03-01
coleção:	BMC Cancer
Assuntos:	STAT3/HDAC Isoalantolactone Dual-target inhibitor Radiosensitization Antitumor
Acesso em linha:	https://doi.org/10.1186/s12885-026-15816-7
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!